SFX by Ex Libris Inc.

Title:	Safflower extract: A novel renal fibrosis antagonist that functions by suppressing autocrine TGF-beta
Source:	Journal of Cellular Biochemistry [0730-2312] Yang, Yu-Lin yr:2008

Basic

Full text

Full text available via Wiley Online Library All Journals

Year:

Volume:

Issue:

Start Page:

Full text available via Wiley Online Library Full Collection 2019

Year:

Volume:

Issue:

Start Page:

Full text available via Wiley Online Library STM 2011

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Burgess, Heather A A. "PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis." American journal of physiology. Lung cellular and molecular physiology 288.6 (2005): -53.
description	2.	Wynn, T A A. "Cellular and molecular mechanisms of fibrosis." The Journal of pathology 214.2 (2007): 199-210.
description	3.	Cutroneo, Kenneth R R. "Therapies for bleomycin induced lung fibrosis through regulation of TGF-beta1 induced collagen gene expression." Journal of cellular physiology 211.3 (2007): 585-9.
description	4.	Mizuno, S. "HGF reduces advancing lung fibrosis in mice: a potential role for MMP-dependent myofibroblast apoptosis." The FASEB journal 19.6 (2005): 580-2.
description	5.	Cabrero, A. "Peroxisome proliferator-activated receptors and the control of inflammation." Current drug targets. Inflammation & allergy 1.3 (2002): 243-248.
description	6.	Isobe, M. "Pioglitazone reduces systematic inflammation and improves mortality in apolipoprotein E knockout mice with sepsis." Intensive care medicine 34.7 (2008): 1304-12.
description	7.	Wynn, Thomas A A. "Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases." The journal of clinical investigation 117.3 (2007): 524-9.
description	8.	Wynn, Thomas A A. "Fibrotic disease and the T(H)1/T(H)2 paradigm." Nature reviews. Immunology 4.8 (2004): 583-94.
description	9.	Huaux, F. "Role of Eotaxin-1 (CCL11) and CC chemokine receptor 3 (CCR3) in bleomycin-induced lung injury and fibrosis." The American journal of pathology 167.6 (2005): 1485-1496.
description	10.	Sorrell JM, Arnold I I. "Clonal characterization of fibroblasts in the superficial layer of the adult human dermis." Cell and tissue research 327.3 (2007): 499-510.
description	11.	Abraham, David J J. "TGF-beta signaling and the fibrotic response." The FASEB journal 18.7 (2004): 816-27.
description	12.	Zeisberg, Elisabeth M M. "Endothelial-to-mesenchymal transition contributes to cardiac fibrosis." Nature medicine 13.8 (2007): 952-61.
description	13.	Cawston, Tim E E. "Matrix metalloproteinase knockout studies and the potential use of matrix metalloproteinase inhibitors in the rheumatic diseases." Current drug targets. Inflammation & allergy 4.3 (2005): 363-75.
description	14.	Pancré, V. "Schistosomal egg antigen-responsive CD8 T-cell population in Schistosoma mansoni-infected BALB/c mice." Immunology 98.4 (2000): 525-34.
description	15.	Bierie, B.. "TGF-beta and cancer." Cytokine & growth factor reviews 17.1-2 (2006): 29-40.
description	16.	Theocharisa, S. "Peroxisome proliferator activated receptor-gamma ligands as potent antineoplastic agents." Current medicinal chemistry. Anti-cancer agents 3.3 (2003): 239-51.
description	17.	Jiang, H. "Comparative proteomic profiles of the hepatopancreas in Fenneropenaeus chinensis response to hypoxic stress." Proteomics 8.17 (2009): 3353-3367.
description	18.	Kintscher, U. "Pharmacological differences of glitazones: does peroxisome proliferator-activated receptor-alpha activation make the difference?" Journal of the American College of Cardiology 52.10 (2008): 882-4.
description	19.	Molina, V. "Immunomodulation of experimental pulmonary fibrosis by intravenous immunoglobulin (IVIG)." Autoimmunity 39.8 (2006): 711-7.
description	20.	Honda T, M. "Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia-reperfusion injury in mice with metabolic disorders." Journal of Molecular and Cellular Cardiology 44.5 (2008): 915-26.